Megadeal Mania
The world of big business deals is booming, with global merger activity up 30% to $1.89 trillion. This collection features the financial powerhouses behind these massive transactions – the investment banks, advisory firms, and private equity giants that stand to profit from the deal-making surge.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Goldman Sachs Group, Inc., The
GS
Current price
$721.38
As a leading global investment bank, Goldman Sachs is explicitly mentioned in the report as leading dealmaking, positioning it to directly capitalize ...
As a leading global investment bank, Goldman Sachs is explicitly mentioned in the report as leading dealmaking, positioning it to directly capitalize on the surge in M&A advisory fees.
Morgan Stanley
MS
Current price
$144.07
Morgan Stanley is a top-tier M&A advisor that stands to benefit from the significant increase in the value and volume of large-scale corporate transac...
Morgan Stanley is a top-tier M&A advisor that stands to benefit from the significant increase in the value and volume of large-scale corporate transactions.
JPMorgan Chase & Co.
JPM
Current price
$290.66
JPMorgan's extensive investment banking division is a key player in structuring and financing megadeals, making it a primary beneficiary of increased ...
JPMorgan's extensive investment banking division is a key player in structuring and financing megadeals, making it a primary beneficiary of increased M&A activity.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Megadeals (transactions over $10 billion) have surged by an impressive 74% year-over-year, signaling a wave of corporate confidence. These financial intermediaries are uniquely positioned to benefit from this trend, earning substantial fees from advising on, structuring, and financing these massive transactions.
What You Need to Know
These stocks tend to perform best during periods of economic expansion and market optimism. When companies feel confident enough to pursue large acquisitions, these financial firms directly benefit through advisory fees, financing arrangements, and strategic services that generate significant revenue.
Why These Stocks
This collection includes industry-leading investment banks, specialized M&A advisory firms, and major private equity players. Each company was selected for its strong position in facilitating large corporate transactions and its ability to capitalize on the current deal-making boom.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+1.01%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 1.01% over the next year.
Stocks Rated Buy by Analysts
9 of 15 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 1% return last month.
Why You'll Want to Watch These Stocks
The Deal Wave Is Here
With megadeal activity skyrocketing 74%, these financial giants are suddenly in high demand. Their specialized services become essential when billion-dollar transactions are on the table.
Fee Revenue Bonanza
M&A advisory fees can be massive - sometimes reaching tens or even hundreds of millions for a single transaction. As deal values climb to $1.89 trillion, so do the potential earnings for these firms.
Hidden Economic Signal
Rising M&A activity often signals broader economic confidence that other investors might miss. These stocks could be early indicators of a positive market shift that's just beginning to take shape.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.